GCG and Hyperglycemia: In addition, we IP injected GRA into LLC-tumor bearing mice to blunt glucagon response for 7 days and observed no effects on tumor growth but significant improvements in weight decline, hyperglycemia, loss of muscle and fat, and hepatic glycogen depletion (Fig. 6j‒m and Supplementary Figs. S9i–k, S10c).